Mirjam Boelens to Humans
This is a "connection" page, showing publications Mirjam Boelens has written about Humans.
Connection Strength
0.155
-
Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. Cell. 2014 Oct 23; 159(3):499-513.
Score: 0.017
-
A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. Lung Cancer. 2011 May; 72(2):177-83.
Score: 0.013
-
Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer. J Pathol. 2009 Jun; 218(2):182-91.
Score: 0.012
-
Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis. Lung Cancer. 2009 Dec; 66(3):372-8.
Score: 0.011
-
Microarray amplification bias: loss of 30% differentially expressed genes due to long probe - poly(A)-tail distances. BMC Genomics. 2007 Aug 15; 8:277.
Score: 0.010
-
Differential expression and distribution of epithelial adhesion molecules in non-small cell lung cancer and normal bronchus. J Clin Pathol. 2007 Jun; 60(6):608-14.
Score: 0.009
-
Optimized whole-genome sequencing workflow for tumor diagnostics in routine pathology practice. Nat Protoc. 2024 Mar; 19(3):700-726.
Score: 0.008
-
Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics. Genet Med. 2024 Feb; 26(2):101032.
Score: 0.008
-
A review on genetic alterations in CNS metastases related to breast cancer treatment. Is there a role for liquid biopsies in CSF? J Neurooncol. 2023 Mar; 162(1):1-13.
Score: 0.007
-
CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer. Nat Commun. 2023 01 12; 14(1):183.
Score: 0.007
-
combination of vascular endothelial growth factor (VEGF) and thymidine phosphorylase (TP) to improve angiogenic gene therapy. Angiogenesis. 2003; 6(3):185-92.
Score: 0.007
-
Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics. J Mol Diagn. 2021 07; 23(7):816-833.
Score: 0.007
-
RET Fluorescence In Situ Hybridization Analysis Is a Sensitive but Highly Unspecific Screening Method for RET Fusions in Lung Cancer. J Thorac Oncol. 2021 05; 16(5):798-806.
Score: 0.006
-
Mutational profiles associated with resistance in patients with BRAFV600E mutant colorectal cancer treated with cetuximab and encorafenib +/- binimetinib or alpelisib. Br J Cancer. 2021 01; 124(1):176-182.
Score: 0.006
-
Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations. Oncologist. 2021 08; 26(8):e1347-e1358.
Score: 0.006
-
The force of HER2 - A druggable target in NSCLC? Cancer Treat Rev. 2020 Jun; 86:101996.
Score: 0.006
-
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2ß. Lab Invest. 2018 01; 98(1):117-129.
Score: 0.005
-
Modeling invasive lobular breast carcinoma by CRISPR/Cas9-mediated somatic genome editing of the mammary gland. Genes Dev. 2016 06 15; 30(12):1470-80.
Score: 0.005
-
Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J. 2011 Aug 26; 30(21):4500-14.
Score: 0.003